Skip to main content
Galapagos NV logo

Galapagos NV — Investor Relations & Filings

Ticker · GLPG ISIN · BE0003818359 LEI · 549300QKJ78IY0IOV655 BR Manufacturing
Open in API
Filings indexed 2,865 across all filing types
Latest filing 2017-12-11 Declaration of Voting R…
Country BE Belgium
Listing BR GLPG

About Galapagos NV

https://www.glpg.com/

Galapagos NV is a biotechnology company focused on transforming patient outcomes through scientific innovation. The company is strategically concentrating its efforts on its cell therapy platform, which is engineered for the scalable, decentralized, and rapid production of next-generation treatments. A key feature of this platform is a median 7-day vein-to-vein delivery time. In parallel with this focus, Galapagos is actively seeking partners to take over its portfolio of small molecule assets, including its TYK2 inhibitor program for autoimmune indications. This strategic shift allows the company to prioritize the growth and development of its cell therapy pipeline through internal discovery, partnerships, and acquisitions.

Recent filings

Filing Released Lang Actions
FMR TP _7DEC2017_NL_def.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is titled "Transparantieverklaring" (Transparency Declaration) and explicitly states that Galapagos NV received a notification of a significant shareholding (kennisgeving van belangrijke deelneming) from FMR LLC. It details the exact number of shares held (4.99%) and notes that the holding dropped below the 5% notification threshold. This content directly corresponds to the definition of a Major Shareholding Notification, which involves reporting changes in significant share ownership levels crossing thresholds. The appropriate code is MRQ.
2017-12-11 Dutch
Galapagos to enter NASDAQ Biotech Index
Regulatory Filings Classification · 95% confidence The document is a short announcement dated December 11, 2017, stating that Galapagos NV will be included in the NASDAQ Biotech Index, effective December 18, 2017. This is a specific, non-financial, operational/market announcement regarding index inclusion, which is not covered by the primary financial filing codes (10-K, IR, ER, etc.). It does not relate to dividends, management changes, director dealings, or capital structure changes directly. Given the specific nature of the announcement (index inclusion) and the lack of a better fit among the detailed categories, it falls best under the general 'Regulatory Filings' category as a miscellaneous regulatory/exchange announcement, or potentially 'RPA' if interpreted as announcing market news, but 'RNS' (Regulatory Filings) is the standard fallback for such specific, non-core announcements.
2017-12-11 English
Galapagos to enter NASDAQ Biotech Index
Regulatory Filings Classification · 95% confidence The document is a short press release dated December 11, 2017, announcing that Galapagos NV will be included in the NASDAQ Biotech Index (NBI) starting December 18, 2017. This is a specific, non-periodic corporate announcement regarding market index inclusion, which is not covered by the major financial filing types (10-K, IR, ER, etc.). It is a general regulatory/market announcement that does not fit into the more specific categories like Director's Dealing (DIRS), Dividend Notice (DIV), or Capital Change (CAP). Therefore, the most appropriate fallback category is Regulatory Filings (RNS), as it is a general market update/announcement.
2017-12-11 English
Galapagos increases share capital through warrant exercises
Share Issue/Capital Change Classification · 99% confidence The document explicitly announces an increase in share capital resulting from warrant exercises, detailing the number of new shares issued and the total capital increase amount. It also provides updated figures for total share capital, securities conferring voting rights, and outstanding warrants, referencing Belgian transparency legislation. This content directly relates to changes in the company's capital structure and share count, fitting the definition of 'Share Issue/Capital Change' (SHA). It is not a general earnings release (ER), a full annual report (10-K), or a simple dividend notice (DIV).
2017-11-24 English
Galapagos increases share capital through warrant exercises
Share Issue/Capital Change Classification · 99% confidence The document explicitly announces a capital increase ('kapitaalverhoging') resulting from the exercise of warrants ('uitoefening van warrants'). It details the number of new shares issued, the total capital raised (€353,835.00), and updates the total number of voting rights and outstanding warrants, referencing Belgian transparency legislation. This content directly relates to changes in the company's capital structure and financing activities. This aligns perfectly with the definition for 'Capital/Financing Update' (CAP). It is not an earnings release, an annual report, or a management discussion, but a specific announcement about capital structure modification.
2017-11-24 English
6-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed with the SEC by a foreign private issuer, Galapagos NV. Form 6-K is used by foreign private issuers to furnish reports or other documents that are required to be made public under the laws of their home country or exchange rules. The document includes a press release as Exhibit 99.1, but the main text is a short report referencing the press release. The document length is only 2593 characters, which is quite short and does not contain detailed financial statements or substantive financial data. It primarily serves as a regulatory filing to provide information to the SEC and investors. According to the rules, such filings that do not contain full reports but provide regulatory information or press releases are classified as Regulatory Filings (RNS).
2017-11-24 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.